GLP-1 Support EXECUTIVE SUMMARY The Opportunity 12 million Americans are currently on GLP-1 medications (Ozempic, Wegovy, Mounjaro) for weight loss, with projections reaching 15+ million by end of 2026
The American Association for the Study of Liver Diseases (AASLD) recommends addressing alcohol use as a primary intervention for liver health
The risks are variable potency, contamination, and lack of large-scale safety data
Penta deca peptide arginate typically costs more per unit than BPC-157 acetate, but the improved oral bioavailability can make it more cost-effective on a per-effective-dose basis for oral protocols
Severe hypoglycemia requires emergency glucagon administration and medical attention
Nutritional Neurohacking Nutritional Neurohacking Last Section Update: 04/2025 Contributor(s) : Maureen Williams, ND